• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

教程:临床药代动力学研究的统计分析和报告。

Tutorial: Statistical analysis and reporting of clinical pharmacokinetic studies.

机构信息

Clinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark.

Department of Regional Health Research, University of Southern Denmark, Odense, Denmark.

出版信息

Clin Transl Sci. 2022 Aug;15(8):1856-1866. doi: 10.1111/cts.13305. Epub 2022 Jun 1.

DOI:10.1111/cts.13305
PMID:35570335
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9372427/
Abstract

Pharmacokinetics is the cornerstone of understanding drug absorption, distribution, metabolism, and elimination. It is also the key to describing variability in drug response caused by drug-drug interactions (DDIs), pharmacogenetics, impaired kidney and liver function, etc. This tutorial aims to provide a guideline and step-by-step tutorial on essential considerations when designing clinical pharmacokinetic studies and reporting results. This includes a comprehensive guide on how to conduct the statistical analysis and a complete code for the statistical software R. As an example, we created a mock dataset simulating a clinical pharmacokinetic DDI study with 12 subjects who were administered 2 mg oral midazolam with and without an inducer of cytochrome P450 3A. We provide a step-by-step guide to the statistical analysis of this clinical pharmacokinetic study, including sample size/power calculation, descriptive statistics, noncompartmental analyses, and hypothesis testing. The different analyses and parameters are described in detail, and we provide a complete R code ready to use in supplementary files. Finally, we discuss important considerations when designing and reporting clinical pharmacokinetic studies. The scope of this tutorial is not limited to DDI studies, and with minor adjustments, it applies to all types of clinical pharmacokinetic studies. This work was done by early career researchers for early career researchers. We hope this tutorial may help early career researchers when getting started on their own pharmacokinetic studies. We encourage you to use this as an inspiration and starting point and continuously evolve your statistical skills.

摘要

药代动力学是理解药物吸收、分布、代谢和消除的基础。它也是描述药物相互作用(DDI)、药物遗传学、肾功能和肝功能受损等引起的药物反应变异性的关键。本教程旨在为设计临床药代动力学研究和报告结果时的基本考虑因素提供指导和分步教程。这包括如何进行统计分析的综合指南和统计软件 R 的完整代码。作为一个示例,我们创建了一个模拟临床药代动力学 DDI 研究的模拟数据集,该研究涉及 12 名受试者,他们分别服用 2mg 口服咪达唑仑和不服用细胞色素 P450 3A 诱导剂。我们提供了对该临床药代动力学研究进行统计分析的分步指南,包括样本量/功效计算、描述性统计、非房室分析和假设检验。不同的分析和参数都有详细描述,并在补充文件中提供了一个完整的 R 代码,可直接使用。最后,我们讨论了设计和报告临床药代动力学研究时的重要考虑因素。本教程的范围不仅限于 DDI 研究,只需进行微小调整,即可适用于所有类型的临床药代动力学研究。这项工作是由早期职业研究人员为早期职业研究人员完成的。我们希望本教程可以帮助早期职业研究人员在开始自己的药代动力学研究时提供帮助。我们鼓励您将其用作灵感和起点,并不断发展您的统计技能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/599b/9372427/aced5c112a1f/CTS-15-1856-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/599b/9372427/e1e8f3cbc6f5/CTS-15-1856-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/599b/9372427/a7fedb038ceb/CTS-15-1856-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/599b/9372427/aced5c112a1f/CTS-15-1856-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/599b/9372427/e1e8f3cbc6f5/CTS-15-1856-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/599b/9372427/a7fedb038ceb/CTS-15-1856-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/599b/9372427/aced5c112a1f/CTS-15-1856-g003.jpg

相似文献

1
Tutorial: Statistical analysis and reporting of clinical pharmacokinetic studies.教程:临床药代动力学研究的统计分析和报告。
Clin Transl Sci. 2022 Aug;15(8):1856-1866. doi: 10.1111/cts.13305. Epub 2022 Jun 1.
2
Critical Impact of Drug-Drug Interactions via Intestinal CYP3A in the Risk Assessment of Weak Perpetrators Using Physiologically Based Pharmacokinetic Models.基于生理的药代动力学模型评估弱作用药物相互作用的风险:肠道 CYP3A 介导的药物相互作用的关键影响
Drug Metab Dispos. 2020 Apr;48(4):288-296. doi: 10.1124/dmd.119.089599. Epub 2020 Jan 29.
3
A semiphysiological population pharmacokinetic model for dynamic inhibition of liver and gut wall cytochrome P450 3A by voriconazole.伏立康唑对肝和肠壁细胞色素 P4503A 动态抑制的拟生理群体药代动力学模型。
Clin Pharmacokinet. 2013 Sep;52(9):763-81. doi: 10.1007/s40262-013-0070-9.
4
A Novel Study Design Using Continuous Intravenous and Intraduodenal Infusions of Midazolam and Voriconazole for Mechanistic Quantitative Assessment of Hepatic and Intestinal CYP3A Inhibition.一种新型研究设计,使用咪达唑仑和伏立康唑的连续静脉内和十二指肠内输注,用于对肝和肠 CYP3A 抑制的机制定量评估。
J Clin Pharmacol. 2020 Sep;60(9):1237-1253. doi: 10.1002/jcph.1619. Epub 2020 May 19.
5
Physiologically Based Pharmacokinetic Modeling of Palbociclib.哌柏西利的生理药代动力学建模
J Clin Pharmacol. 2017 Feb;57(2):173-184. doi: 10.1002/jcph.792. Epub 2016 Aug 22.
6
Predictions of metabolic drug-drug interactions using physiologically based modelling: Two cytochrome P450 3A4 substrates coadministered with ketoconazole or verapamil.基于生理的药物相互作用代谢预测模型:酮康唑或维拉帕米合用两种细胞色素 P450 3A4 底物。
Clin Pharmacokinet. 2010 Apr;49(4):239-58. doi: 10.2165/11318130-000000000-00000.
7
Drug-Drug Interaction Risk Assessment of Esaxerenone as a Perpetrator by In Vitro Studies and Static and Physiologically Based Pharmacokinetic Models.依体外研究与静态及生理为基础之药动学模型评估 esaxerenone 作为药物交互作用之肇因者的风险。
Drug Metab Dispos. 2020 Sep;48(9):769-777. doi: 10.1124/dmd.120.090928. Epub 2020 Jul 2.
8
Physiologically based pharmacokinetic modeling to predict complex drug-drug interactions: a case study of AZD2327 and its metabolite, competitive and time-dependent CYP3A inhibitors.基于生理的药代动力学建模以预测复杂的药物-药物相互作用:以AZD2327及其代谢物、竞争性和时间依赖性CYP3A抑制剂为例的研究
Biopharm Drug Dispos. 2015 Nov;36(8):507-19. doi: 10.1002/bdd.1962. Epub 2015 Jul 27.
9
Physiologically based pharmacokinetic model of mechanism-based inhibition of CYP3A by clarithromycin.基于生理学的克拉霉素对 CYP3A 机制性抑制的药代动力学模型。
Drug Metab Dispos. 2010 Feb;38(2):241-8. doi: 10.1124/dmd.109.028746. Epub 2009 Nov 2.
10
Midazolam Limited Sampling Strategy With a Population Pharmacokinetic Approach to Simultaneously Estimate Cytochrome P450 (CYP) 3A Constitutive, Inhibition, and Induction/Activation Conditions in Healthy Adults.米达唑仑有限采样策略与群体药代动力学方法联合评估健康成年人细胞色素 P450(CYP)3A 组成、抑制、诱导/激活状态。
J Clin Pharmacol. 2019 Nov;59(11):1495-1504. doi: 10.1002/jcph.1440. Epub 2019 May 3.

引用本文的文献

1
Limited Sampling Strategies to Predict Mycophenolic Acid and Tacrolimus Area Under the Concentration-Time Curve in Steroid-Free Kidney Transplant Patients.预测无类固醇肾移植患者霉酚酸和他克莫司浓度-时间曲线下面积的有限采样策略
Basic Clin Pharmacol Toxicol. 2025 Jul;137(1):e70056. doi: 10.1111/bcpt.70056.
2
Genetically Modified Mesenchymal Stromal/Stem Cells as a Delivery Platform for SE-33, a Cathelicidin LL-37 Analogue: Preclinical Pharmacokinetics and Tissue Distribution in C57BL/6 Mice.基因工程改造的间充质基质/干细胞作为抗菌肽LL-37类似物SE-33的递送平台:C57BL/6小鼠的临床前药代动力学和组织分布
Antibiotics (Basel). 2025 Apr 24;14(5):429. doi: 10.3390/antibiotics14050429.
3

本文引用的文献

1
Planning and Conducting a Pharmacogenetics Association Study.规划和进行药物遗传学关联研究。
Clin Pharmacol Ther. 2021 Sep;110(3):688-701. doi: 10.1002/cpt.2270. Epub 2021 Jun 19.
2
Guidelines for Reporting of Figures and Tables for Clinical Research in Urology.泌尿外科临床研究报告图和表的指南。
BJU Int. 2020 Jul;126(1):14-25. doi: 10.1111/bju.15102. Epub 2020 Jun 15.
3
New Author Guidelines for Displaying Data and Reporting Data Analysis and Statistical Methods in Experimental Biology.实验生物学中展示数据和报告数据分析及统计方法的新作者指南。
Population Pharmacokinetics of IV Lidocaine and its Metabolites in Adult Surgical Patients.
静脉注射利多卡因及其代谢产物在成年外科患者中的群体药代动力学
Pharm Res. 2025 Mar;42(3):451-473. doi: 10.1007/s11095-025-03835-1. Epub 2025 Feb 28.
4
Innovations in Biosensor Technologies for Healthcare Diagnostics and Therapeutic Drug Monitoring: Applications, Recent Progress, and Future Research Challenges.生物传感器技术在医疗诊断和治疗药物监测中的创新应用:应用、最新进展和未来研究挑战。
Sensors (Basel). 2024 Aug 8;24(16):5143. doi: 10.3390/s24165143.
5
Dicloxacillin is an inducer of intestinal P-glycoprotein but neither dicloxacillin nor flucloxacillin increases the risk of stroke/systemic embolism in direct oral anticoagulant users.双氯西林是肠道 P 糖蛋白的诱导剂,但无论是双氯西林还是氟氯西林,都不会增加直接口服抗凝剂使用者中风/全身性栓塞的风险。
Br J Clin Pharmacol. 2024 Dec;90(12):3252-3262. doi: 10.1111/bcp.16190. Epub 2024 Aug 19.
6
Variability in plasma rifampicin concentrations and role of , , and genotypes in Ethiopian patients with tuberculosis.埃塞俄比亚结核病患者血浆中利福平浓度的变异性以及、、和基因型的作用。
Infect Dis (Lond). 2024 Apr;56(4):308-319. doi: 10.1080/23744235.2024.2309348. Epub 2024 Feb 5.
7
Advancing Subcutaneous Dosing Regimens for Biotherapeutics: Clinical Strategies for Expedited Market Access.推进生物疗法的皮下给药方案:加速市场准入的临床策略。
BioDrugs. 2024 Jan;38(1):23-46. doi: 10.1007/s40259-023-00626-1. Epub 2023 Oct 13.
8
Cytochrome P450 activity in rheumatoid arthritis patients during continuous IL-6 receptor antagonist therapy.类风湿关节炎患者在持续接受白细胞介素 6 受体拮抗剂治疗期间细胞色素 P450 的活性。
Eur J Clin Pharmacol. 2023 Dec;79(12):1687-1698. doi: 10.1007/s00228-023-03578-1. Epub 2023 Oct 13.
Drug Metab Dispos. 2020 Jan;48(1):64-74. doi: 10.1124/dmd.119.090027.
4
Clinical Studies on Drug-Drug Interactions Involving Metabolism and Transport: Methodology, Pitfalls, and Interpretation.涉及代谢和转运的药物-药物相互作用的临床研究:方法学、陷阱和解读。
Clin Pharmacol Ther. 2019 Jun;105(6):1345-1361. doi: 10.1002/cpt.1435. Epub 2019 Apr 20.
5
Optimization of a drug transporter probe cocktail: potential screening tool for transporter-mediated drug-drug interactions.优化药物转运体探针鸡尾酒:用于筛查药物-药物相互作用的潜在工具
Br J Clin Pharmacol. 2018 Sep;84(9):1941-1949. doi: 10.1111/bcp.13609. Epub 2018 Jun 21.
6
What Does It "Mean"? A Review of Interpreting and Calculating Different Types of Means and Standard Deviations.这是什么“意思”?解读与计算不同类型均值和标准差的综述。
Pharmaceutics. 2017 Apr 13;9(2):14. doi: 10.3390/pharmaceutics9020014.
7
In vivo Phenotyping Methods: Cytochrome P450 Probes with Emphasis on the Cocktail Approach.体内表型分析方法:细胞色素P450探针,重点介绍鸡尾酒法。
Curr Pharm Des. 2017;23(14):2035-2049. doi: 10.2174/1381612823666170207100724.
8
Statistical tests, P values, confidence intervals, and power: a guide to misinterpretations.统计检验、P 值、置信区间与检验效能:误解指南
Eur J Epidemiol. 2016 Apr;31(4):337-50. doi: 10.1007/s10654-016-0149-3. Epub 2016 May 21.
9
A diagnostic tool for population models using non-compartmental analysis: The ncappc package for R.一种使用非房室分析的种群模型诊断工具:用于R语言的ncappc软件包。
Comput Methods Programs Biomed. 2016 Apr;127:83-93. doi: 10.1016/j.cmpb.2016.01.013. Epub 2016 Feb 17.
10
Experimental design and analysis and their reporting: new guidance for publication in BJP.实验设计与分析及其报告:发表于《英国药理学杂志》的新指南
Br J Pharmacol. 2015 Jul;172(14):3461-71. doi: 10.1111/bph.12856.